CIMT and Plaque Assessment Findings in Subjects Undergoing Stress Echocardiography For Risk Stratification
NCT ID: NCT02245048
Last Updated: 2023-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
73 participants
OBSERVATIONAL
2014-10-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients who agree to participate wil undergo non-invasive carotid intima-media thickness (CIMT) measurement and plaque assessment. Findings of CIMT will be compared to results of patient standard of care stress echocardiogram (SE) and of diastolic function.
We hypothesize tht 1) in patients undergoing SE for inappropriate or uncertain indications, CIMT and plaque assessment will provide useful risk stratification beyond use of traditional risk factors; 2) CIMT findings will correlate with results of SE in terms of exercise capacity and 3) Exercise capacity will correlate with diastolic function.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography
NCT01581671
New Technologies to Determine Carotid Plaque Vulnerability
NCT02224339
Carotid Ultrasound Sub-Study of the Familial Atherosclerosis Study-observational Study
NCT00976014
A Study on Intima Media Thickness (IMT) in Middle-aged Subjects
NCT00784264
Advanced Ultrasound Methods in the Assessment of Carotid Plaque Instability
NCT03672955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stress Echocardiography (SE)
Subjects will undergo CIMT measurements.
Carotid Intima-Media Thickness (CIMT)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carotid Intima-Media Thickness (CIMT)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No prior cardiac history (MI, PTCA, CABG, angina)
* No peripheral vascular disease
* No history of stroke or TIA
* Statins, antihypertensives, ASA treatment OK
Exclusion Criteria
* History of stroke/TIA/peripheral vascular disease
* Inability to exercise on the treadmill
* Unwilling/unable to sign informed consent
* History of neck radiation or neck surgery or inability to obtain neck images
* End stage renal disease
* Preoperative evaluation
* History of chest pain
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Esaote North America
UNKNOWN
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tasneem Z. Naqvi, M.D.
PI
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tasneem Naqvi, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Scottsdale, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-008535
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.